Brokerages Set UiPath Inc. (NYSE:PATH) Price Target at $27.41

UiPath Inc. (NYSE:PATH) has received a consensus rating of “Moderate Buy” from the eighteen ratings firms that are covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $27.41.

A number of equities research analysts recently issued reports on PATH shares. JPMorgan Chase & Co. raised shares of UiPath from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $22.00 to $28.00 in a report on Thursday, March 14th. TD Cowen upped their price objective on shares of UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, March 14th. Wells Fargo & Company upped their target price on shares of UiPath from $24.00 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, March 14th. BMO Capital Markets upped their target price on shares of UiPath from $24.00 to $28.00 and gave the company a “market perform” rating in a research report on Thursday, March 14th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $32.00 target price on shares of UiPath in a research report on Wednesday, March 20th.

UiPath Stock Down 2.8 %

UiPath stock opened at $20.71 on Tuesday. UiPath has a 52-week low of $12.38 and a 52-week high of $27.87. The company has a fifty day simple moving average of $23.30 and a 200-day simple moving average of $21.40. The firm has a market capitalization of $11.78 billion, a price-to-earnings ratio of -121.82 and a beta of 0.96.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The firm had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. On average, research analysts anticipate that UiPath will post -0.04 EPS for the current fiscal year.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 16,000 shares of the stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the sale, the chief financial officer now owns 87,505 shares of the company’s stock, valued at $1,998,614.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last quarter, insiders have sold 72,000 shares of company stock valued at $1,591,360. 31.03% of the stock is currently owned by corporate insiders.

Institutional Trading of UiPath

Hedge funds have recently added to or reduced their stakes in the company. Mark Sheptoff Financial Planning LLC acquired a new stake in UiPath in the fourth quarter valued at approximately $25,000. HighMark Wealth Management LLC purchased a new position in UiPath in the fourth quarter valued at approximately $27,000. Cypress Capital Management LLC WY purchased a new position in UiPath in the fourth quarter valued at approximately $29,000. GAMMA Investing LLC purchased a new position in UiPath in the fourth quarter valued at approximately $36,000. Finally, Mango Five Family Inc. purchased a new position in UiPath in the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.